Arrowstreet Capital, Limited Partnership Atri Cure, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Atri Cure, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 69,025 shares of ATRC stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,025
Previous 9,996
590.53%
Holding current value
$1.55 Million
Previous $357,000
488.24%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ATRC
# of Institutions
239Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA4.75MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.23MShares$94.7 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$81.8 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$60 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$36.7 Million0.01% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.04B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...